Latest News & Features
Americas
A judge at the US District Court for the Southern District of Indiana has handed down a final judgment in a patent dispute between Eli Lilly and Sun Pharmaceutical favouring Eli Lilly. 3 May 2017
Americas
GSK and biotech company Bluebird Bio have entered into a licence agreement centring on Bluebird’s lentiviral vector platform. 3 May 2017
Americas
The number of Abbreviated New Drug Application disputes filed in 2016 represented a drop for the first time in three years, the newly published “Hatch-Waxman ANDA Litigation Report 2017” has said. 2 May 2017
Americas
The US Court of Appeals for the Federal Circuit ruled yesterday that a patent is invalid if the invention was sold before being patented, even if the invention was not publicly disclosed. 2 May 2017
Americas
The US District Court for the District of Delaware has dismissed a dispute between Apotex and Allergan after the companies entered into a settlement agreement. 28 April 2017
Biotechnology
Merck will divest its biosimilars business to Fresenius Kabi in order to focus on innovative drugs. 28 April 2017
Americas
The US Supreme Court heard oral arguments from Amgen and Sandoz yesterday in the ongoing battle over a biosimilar version of Amgen’s Neupogen. 27 April 2017
Americas
The US Court of Appeals for the Federal Circuit has partly affirmed, partly reversed and partly vacated a dispute between Duke University, based in North Carolina, and biotech company BioMarin Pharmaceutical. 27 April 2017
Americas
Merck and PDL Biopharma have settled a dispute over Merck’s cancer drug Keytruda (pembrolizumab), which allegedly infringed a patent belonging to PDL. 27 April 2017
Americas
LSIPR and law firm HGF held a webinar yesterday focusing on CRISPR and how to navigate the IP landscape. 26 April 2017